There is no single established cause of prostate cancer in the way that persistent high-risk HPV is the central cause of nearly all cervical cancers. Instead, prostate cancer develops through genetic and cellular changes that accumulate within prostate cells, with risk influenced by age, inherited susceptibility, ethnicity and family history and potentially by other biological and environmental factors. Cancer is fundamentally a genetic disease in the sense that malignant cells acquire changes in genes controlling growth, survival and DNA repair. Those genetic changes may arise during life or, in a minority of cases, be partly related to inherited variants that increase susceptibility.
Age is the strongest established risk factor for prostate cancer. As people age, cells undergo repeated cycles of replication and repair, providing opportunities for DNA alterations to accumulate. Cellular repair mechanisms also become less effective with age, and the immune system's ability to eliminate abnormal cells changes over the lifespan. Age does not mean that cancer is inevitable; rather, increasing age increases the probability that enough cellular changes will accumulate for a malignant clone to emerge. This explains why prostate cancer is predominantly a disease of older adults.
Family history is another important risk factor. A person with a close relative who has had prostate cancer has a higher probability of developing the disease, particularly when several close relatives are affected or when relatives were diagnosed at younger ages. Family clustering can reflect inherited genetic susceptibility, shared environmental exposures or combinations of both. A family history of breast, ovarian or pancreatic cancer can also be relevant because some families carry inherited variants, including changes in BRCA genes, that increase the risk of several different cancers.
Inherited BRCA2 alterations are among the better-established genetic risk factors for prostate cancer. BRCA1 and BRCA2 participate in DNA repair, so certain inherited pathogenic variants can impair the cell's ability to repair particular forms of DNA damage accurately. People inheriting such variants do not automatically develop cancer; inheritance changes susceptibility rather than determining the outcome. BRCA2-associated prostate cancers can also have more aggressive biological characteristics in some individuals. Other inherited genetic alterations can contribute to prostate-cancer risk, and genetic testing may therefore have implications for selected people with strong family histories or particular cancer patterns.
Ethnicity is associated with substantial differences in prostate-cancer incidence and mortality. Prostate cancer is more common in Black men than in White men and less common in Asian men in UK population data. The reasons are not completely explained by a single factor and probably involve interactions among genetics, environmental exposures, healthcare access, socioeconomic circumstances and other determinants. Ethnicity should therefore be understood as a population-level risk association rather than as a biological destiny for an individual.
Researchers have investigated lifestyle and environmental factors including body weight, diet, hormone levels and occupational or chemical exposures. Some associations have been observed, but evidence is not equally strong for all proposed causes, and many popular claims about specific foods, supplements or sexual behaviours are not established explanations for prostate cancer. Cancer Research UK notes that prostate cancer is not clearly linked to preventable causes in the same way as some other cancers. Consequently, it is misleading to attribute an individual diagnosis to one particular food, activity or lifestyle choice without strong evidence.
Prostate cancer arises through the interaction of genetic alterations and the biological environment of prostate tissue. Androgen hormones, particularly testosterone and its metabolite dihydrotestosterone, have an important role in normal prostate biology and in the growth of many prostate cancers, which is why androgen-deprivation therapy is an important treatment for advanced or hormone-sensitive disease. Hormonal signalling is therefore relevant to tumour growth, but it should not be interpreted as meaning that normal testosterone exposure alone causes prostate cancer. Cancer development requires abnormal cellular changes in addition to the tissue's hormonal environment.
The most accurate account of causation is therefore multifactorial: ageing provides the strongest population-level risk, while family history, inherited genetic variants and ethnicity substantially influence susceptibility, with additional biological and environmental factors potentially contributing. Having a risk factor does not mean that cancer will definitely occur, and lacking known risk factors does not guarantee protection. Most prostate cancers cannot be traced to one preventable exposure. This differs from cancers with a clearly identifiable dominant infectious cause and illustrates a broader principle of cancer biology: malignant transformation usually results from accumulated genetic and cellular alterations rather than one isolated event.
